Electronic Clinical Decision Support for Middle Eastern Hospitals

First DataBankHospitals in the Middle East are set to benefit from sophisticated electronic clinical decision support following the commercial agreement between First DataBank International (FDB International) and GE Healthcare (GE). This agreement builds on the relationship which First DataBank has with GE Healthcare's Information Technology business in the US.

GE's Centricity® Enterprise, will provide Middle Eastern customers with electronic dispensing and prescribing functionality, with clinical decision support enabled by the integration of FDB International's drug knowledge base. Healthcare providers can use Centricity® Enterprise to help verify the medication about to be prescribed or dispensed to a patient against the patient's profile. On-screen alerts help a provider to determine if there may be a potential drug interaction, duplicate therapy, sensitivity, contraindication or precaution.

Centricity® Enterprise is an integrated clinical, financial and administrative system that helps caregivers provide enhanced patient care through computerized physician order entry (CPOE), clinical decision support and expert rules, while documenting all aspects of patient care. The system integrates core clinical processes for orders, results, pharmacy and care documentation, in concert with administrative/financial processes for scheduling, registration/admitting, charging and billing.

"This agreement gives us access to invaluable information which will immediately benefit our product," said Juergen Reyinger, EMEA vice president and general manager of GE Healthcare IT. "We look forward to working with First DataBank International in growing our solution and benefiting from their strengths, just as they will surely benefit from ours."

David Flavell, President, FDB International adds: "The Middle East is a key region in our international expansion plans as its healthcare systems are developing so rapidly. Our agreement with GE is significant as it will bring more advanced clinical decision support to hospitals in the region, helping providers to enhance patient safety by helping them reduce the occurrence of medical errors."

First DataBank continues to expand its global presence with customers across the Middle East, Asia Pacific, Australasia, Africa and Europe as well as continuing to grow its long established North American and UK markets.

Related news articles:

About First DataBank
First DataBank (FDB) is the world's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, FDB has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen FDB to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

For further information visit www.firstdatabank.co.uk.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease. For further information visit www.gehealthcare.com.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...